I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Image_3_Dinaciclib as an effective pan-cyclin dependent kin..:
David Howard
;
David James
;
Jezabel Garcia-Parra
...
doi:10.3389/fonc.2022.1014280.s003. , 2022
Link:
https://doi.org/10.3389/fonc.2022.1014280.s003
RT Journal T1
Image_3_Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer.tif
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_21620097&Exemplar=1&LAN=DE A1 David Howard A1 David James A1 Jezabel Garcia-Parra A1 Belen Pan-Castillo A1 Jenny Worthington A1 Nicole Williams A1 Zoe Coombes A1 Sophie Colleen Rees A1 Kerryn Lutchman-Singh A1 Lewis W. Francis A1 Paul Rees A1 Lavinia Margarit A1 R. Steven Conlan A1 Deyarina Gonzalez YR 2022 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 ovarian cancer K1 resistance K1 cyclin dependent kinase inhibitor K1 dinaciclib K1 cisplatin K1 platinum K1 refractory K1 flavopiridol JF doi:10.3389/fonc.2022.1014280.s003 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.1014280.s003 DO https://doi.org/10.3389/fonc.2022.1014280.s003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)